title: [Cost and efficacy of treatment strategies in localized prostatic cancer: feasibility study in the general population].
abstract: OBJECTIVE
  Medico-economic studies are necessary to evaluate healthcare practices. The objective of this preliminary study is to show how this type of study can be conducted in the general population based on cancer registries.
  
  
  METHODS
  122 cases of localized prostate cancer diagnosed in 1995 in the Tarn department were included in this study. A decisional tree of the main diagnostic strategies was elaborated. Direct medical and non-medical costs were considered from the payer's point of view and the 5-year survival was calculated.
  
  
  RESULTS
  The costs of therapeutic management for radical prostatectomy, localized radiotherapy, endocrine therapy and watchful waiting were 55,468, 65,486, 72,211, and 13,929 French francs (8,533, 10,075, 11,109 and 2,143 euros) respectively. The observed 5-year survival was 89%, 84%, 75% and 79% respectively.
  
  
  CONCLUSIONS
  This method can be applied to the CCAFU/FRANCIM cohort derived from 5 departments allowing comparisons between regions and healthcare sectors. The time-course could be determined by follow-up of a cohort of cancers diagnosed in 2001.
authors.affiliation: Inserm U558, Faculté de Médecine de Purpan, Toulouse, France. ericbauv@yahoo.fr
authors.forename: Eric
authors.initials: E
authors.lastname: Bauvin
authors.forename: Laurent
authors.initials: L
authors.lastname: Molinier
authors.forename: Benoît
authors.initials: B
authors.lastname: Dervaux
authors.forename: Michel
authors.initials: M
authors.lastname: Soulié
authors.forename: Igor
authors.initials: I
authors.lastname: Latorzeff
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Bachaud
authors.forename: Arnauld
authors.initials: A
authors.lastname: Villers
authors.forename: Antoine
authors.initials: A
authors.lastname: Elias
authors.forename: Pascale
authors.initials: P
authors.lastname: Grosclaude
mesh_terms: D000368:Aged; D003365:Costs and Cost Analysis; D003663:Decision Trees; D005240:Feasibility Studies; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000191:economics* / Q000628:therapy*; D012189:Retrospective Studies